Bolt Biotherapeutics, Inc. (BOLT)
4.56
-0.05
(-1.08%)
USD |
NASDAQ |
May 21, 16:00
4.56
0.00 (0.00%)
After-Hours: 19:08
Bolt Biotherapeutics Profit Margin (Quarterly) : -27.86K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Humacyte, Inc. | -3.56K% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.14% |
| Return on Assets | -43.91% |
| Return on Invested Capital | -52.48% |
| Gross Profit Margin (Quarterly) | -680.8% |
| Operating Margin (Quarterly) | -29.23K% |
| Return on Net Operating Assets | -137.2% |